Dr. AbdulHamid Lukambagire is a Senior Research Scientist at the Kilimanjaro Clinical Research Institute (KCRI) in Moshi, Tanzania. He holds a PhD in One Health focusing on Evaluation of Diagnostic Technologies for Infectious diseases in low-resource settings. He is also a Fellow of the East African Biosciences Innovation Initiative, themed at the genomics of cancer in African populations. He has previously worked on multiple neglected diseases (NTDs), pioneering research on human fascioliasis in Tanzania with interests in various other parasitic diseases. He has served as a Project Coordinator for numerous One Health projects, recently as a Consultant Field Scientist for the DTRA funded CCHF and BruSTAR projects. With over 38 publications, AbdulHamid actively engages with stakeholders on policy and advocacy for brucellosis in Tanzania, making significant contributions to national policy and guidelines for brucellosis and multiple other zoonoses. AbdulHamid currently serves as the Project Manager for the Rift Valley Epidemiology and Modeling to Inform Human Vaccine Efficacy Trials (REMIT) funded by the Coalition for Epidemic Preparedness Innovations (CEPI) and is the Lead PI of the Rwanda-Tanzania consortium addressing One Health Approaches and Control of Fascioliasis and Schistosomiasis funded by the WHO Special Programme for Research on Tropical Diseases (TDR).